ammonium sulfate has been researched along with fasudil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Gu, S; Li, X; Liu, G; Liu, Y; Wu, X; Zhang, D; Zhang, J; Zhu, G | 1 |
| Asai, T; Fukuta, T; Honda, M; Namba, M; Oku, N; Yamamoto, H; Yanagida, M; Yanagida, Y | 1 |
2 other study(ies) available for ammonium sulfate and fasudil
| Article | Year |
|---|---|
Aptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Ammonium Sulfate; Angiogenesis Inhibitors; Animals; Aptamers, Peptide; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell-Penetrating Peptides; Drug Delivery Systems; Drug Stability; Humans; Liver Neoplasms; Mice, Nude; MicroRNAs; Nanoparticles; Peptides; Polyethylene Glycols; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2016 |
Release rate is a key variable affecting the therapeutic effectiveness of liposomal fasudil for the treatment of cerebral ischemia/reperfusion injury.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1,2-Dipalmitoylphosphatidylcholine; Ammonium Sulfate; Animals; Brain; Citric Acid; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Liberation; Liposomes; Male; Phosphatidylcholines; Quaternary Ammonium Compounds; Rats, Wistar; Reperfusion Injury; Treatment Outcome | 2020 |